1. Tronieri JS, Wadden TA, Chao AM, Tsai AG. Primary care interventions for obesity: review of the evidence. Curr Obes Rep. 2019;8:128-36. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
2. Rojas K, Matthews N, Raker C, Clark MA, Onstad M, Stuckey A, et al. Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship. J Cancer Surviv. 2018;12:127-33. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
3. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. The Journal of clinical investigation. 2017;127(1):1-4. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
4. McNelis JC, Olefsky JM. Macrophages, immunity, and metabolic disease. Immunity. 2014;41(1):36-48. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
5. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, LeBoeuf RC, et al. S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation. 2011;123(11):1216-26. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
6. Tøn H, Brandsnes Ø, Dale S, Holtlund J, Skuibina E, Schjønsby H, et al. Improved assay for fecal calprotectin. Clinica chimica acta. 2000;292(1-2):41-54. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
7. D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2218-24. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
8. Pedersen L, Nybo M, Poulsen MK, Henriksen JE, Dahl J, Rasmussen LM. Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients. BMC Cardiovasc Disord. 2014;14(1):196. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
9. Xu H. Obesity and metabolic inflammation. Drug Discov Today Dis Mech. 2013;10(1-2):e21-5. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
10. Pasdar Y, Darbandi M, Niazi P, Alghasi S, Roshanpour F. The Prevalence and the Affecting Factors of Obesity in Women of Kermanshah. Jorjani Biomed J. 2015;3(1):82-97. [
View at Publisher] [
Google Scholar]
11. Strasser B, Arvandi M, Siebert U. Resistance training, visceral obesity and inflammatory response: a review of the evidence. Obes Rev. 2012;13(7):578-91. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
12. Nicholas L, Morrison J, Rattanatray L, Zhang S, Ozanne S, McMillen I. The early origins of obesity and insulin resistance: timing, programming and mechanisms. Int J Obes (Lond). 2016;40(2):229-38. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
13. Flack K, Davy K, Hulver M, Frisard M, Anderson A, Boutagy N, et al. Resistance Training and Mitochondrial Metabolism. The FASEB Journal. 2015;29(s1):LB363. [
View at Publisher] [
DOI] [
Google Scholar]
14. 14.Fleck SJ, Kraemer W. Designing resistance training programs. 4th ed. US: Human Kinetics; 2014. [
View at Publisher] [
Google Scholar]
15. Knowles OE, Aisbett B, Main LC, Drinkwater EJ, Orellana L, Lamon S. Resistance training and skeletal muscle protein metabolism in eumenorrheic females: implications for researchers and practitioners. Sports Medicine. 2019;49(11):1637-50. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
16. Tresierras MA, Balady GJ. Resistance training in the treatment of diabetes and obesity: mechanisms and outcomes. J Cardiopulm Rehabil Prev. 2009;29(2):67-75. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
17. Olson TP, Dengel D, Leon A, Schmitz K. Changes in inflammatory biomarkers following one-year of moderate resistance training in overweight women. Int J Obes (Lond). 2007;31(6):996-1003. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
18. Alie M, Matinhomaee H, Peeri M. The effect of different resistance training intensities on liver function in obese men. Journal of Sport Biosciences. 2017;9(1):75-92. [
View at Publisher] [
Google Scholar]
19. Fagerhol M, Nielsen H, Vetlesen A, Sandvik K, Lyberg T. Increase in plasma calprotectin during long‐distance running. Scand J Clin Lab Invest. 2005;65(3):211-20. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
20. Mehrabani J, Mirmohamadloo F, Nobari H. The Effect of 8 Weeks of Circuit Resistance Training on Ox-LDL, hs-CRP, HbA1c and Insulin Resistance Index in Sedentary Postmenopausal Women. Sport Physiology & Management Investigations. 2016;8(4):47-57. [
View at Publisher] [
Google Scholar]
21. Maté-Muñoz JL, Monroy AJA, Jiménez PJ, Garnacho-Castaño MV. Effects of instability versus traditional resistance training on strength, power and velocity in untrained men. J Sports Sci Med. 2014;13(3):460-8. [
View at Publisher] [
Google Scholar]
22. Moradi F. Changes of serum adiponectin and testosterone concentrations following twelve weeks resistance training in obese young men. Asian J Sports Med. 2015;6(4):e23808. [
View at Publisher] [
DOI] [
Google Scholar]
23. Azarmehr SA, Toloee MR, Akbari E. The effect of 8 weeks of Circuit Resistance Training on metabolic syndrome risk factors and body composition in women over age 50 with diabetes mellitus type 2. International Journal of Applied Exercise Physiology. 2017;6(3):103-10. [
View at Publisher] [
DOI] [
Google Scholar]
24. Takahashi M, Suzuki K, Matoba H, Sakamoto S, Obara S. Effects of different intensities of endurance exercise on oxidative stress and antioxidant capacity. The Journal of Physical Fitness and Sports Medicine. 2012;1(1):183-9. [
View at Publisher] [
DOI] [
Google Scholar]
25. Fico BG, Slusher AL, Whitehurst M, Maharaj A, Huang C-J. The Impact of Obesity on Calprotectin Response to Acute Aerobic Exercise: 2661 Board# 184 June 3, 9: 30 AM-11: 00 AM. Medicine & Science in Sports & Exercise. 2016;48(5S)(suppl1):743. [
View at Publisher] [
DOI]
26. Calcaterra V, De Amici M, Leonard MM, De Silvestri A, Pelizzo G, Buttari N, et al. Serum calprotectin level in children: marker of obesity and its metabolic complications. Ann Nutr Metab. 2018;73(3):177-83. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
27. Niemelä M, Niemelä O, Bloigu R, Bloigu A, Kangastupa P, Juvonen T. Serum calprotectin, a marker of neutrophil activation, and other mediators of inflammation in response to various types of extreme physical exertion in healthy volunteers. J Inflamm Res. 2020;13:223-31. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
28. Grand A, Rochette E, Dutheil F, Gozal D, Calcaterra V, Berni Canani R, et al. Body mass index and calprotectin blood level correlation in healthy children: an individual patient data meta-analysis. J Clin Med. 2020;9(3):857. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
29. Talebi-Garakani E, Vosough M, Kheradmand S, Fathi R. The effect of eight weeks aerobic exercise training on plasma levels of Calprotectin and insulin resistance in overweight post-menopausal and peri-menopausal women. Journal of Practical Studies of Biosciences in Sport. 2021;9(20):56-66. [
View at Publisher] [
Google Scholar]